Overview

A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy Volunteers

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
GW870086X is a novel inhaled steroid that has an improved safety profile over other steroids but is also less potent. This study will look at higher doses to confirm the improved safety profile.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline